1 Introduction
2 Methods
3 Results
Table 1 Content analysis code book medical category descriptions. |
Category | Description |
---|---|
Covid-19 epidemiology | Epidemiology of Covid-19, including infection rates, patient demographics, risk factors, surveillance systems, modelling/predicting the spread of infection, transmission routes, patterns of infection, factors associated with mortality. May include some discussion of symptoms. |
Covid-19 health service provision | Organisation, provision, staff or support of health services to deal with Covid-19 patients. Includes safety precautions in Covid-19 medical settings, and pharmaceutical industry developments. Excludes health-related increases/decreases in incidence (not reporting) due to pandemic conditions. |
Covid-19 impact on other health services | Changes in uptake or provision of health services for purposes unrelated to Covid-19, such as cancer and surgery, due to Covid-19 healthcare or pandemic safety restrictions. |
Covid-19 medical treatment | Treatments for patients infected with Covid-19, such as antivirals, plasma transfusion, and nutrition. Includes papers investigating properties of potential treatments. Includes articles discussing both diagnosis and treatment. |
Covid-19 safety precautions | Methods or equipment to avoid transmission of Covid-19, other than lockdowns in general, including contact tracing, studies of the prevalence of safety measures or risk awareness (including in general medical training/settings), and urban planning. Risk and safety information communication. |
Covid-19 symptoms | Common and rare symptoms, complications and side-effects of Covid-19 (including conditions “associated with” Covid-19), diagnosed at the time or post mortem, including invisible symptoms (blood changes) and studies of symptom progression over time. |
Covid-19 vaccines | Development, testing, and rollout of Covid-19 vaccines |
Covid-19 virology | Properties of the virus, transmission methods, genomics, mutations, receptors, animal origins, animal coronaviruses specifically linked to Covid-19. |
Covid-19 with another condition | Identification or treatment of other conditions in conjunction with Covid-19 (not caused by Covid-19), including pregnancy; or discussion of other pre-existing conditions shown to exacerbate Covid-19 or to be a risk factor for it. |
Table 2 Content analysis code book non-medical category descriptions. |
Category | Description |
---|---|
Context | Something about Covid-19 is relevant to the study or is used as an example or to illustrate a point in the study or explain some of the study results, but the study is not directly or indirectly about Covid-19. |
Decreased importance due to Covid-19 | The paper implies that the study reported is less important due to Covid-19 (e.g. because lockdown social distancing makes method impossible, or has changed the study context, or limited what was possible to investigate). |
Increased importance due to Covid-19 | The paper implies that the study reported is more important due to Covid-19 (e.g. because the issue investigated has been exacerbated by it) or has a Covid-19-related possible application, including treatment as a minor point. |
Pandemic art | Art or culture during the pandemic. |
Pandemic education | Distance or remote learning as an adaptation to lockdowns or pandemic safety precautions; includes related adaptations to pandemic learning. |
Pandemic economy | Economic or business (including media and non-medical public services) effects of lockdown or strategies for before/after lockdown; either in general or for specific business sectors; also, bibliometric studies of Covid-19. |
Pandemic health | Any aspect of public health, including mental health and physical activities, but not happiness or distress, during pandemic safety measures, excluding Covid-19. |
Pandemic society | Any aspect of public opinion, happiness, distress, work life (except medical workers), remote working, daily life, risk of violence, politics affected by pandemic restrictions. |
Irrelevant | Covid-19 is irrelevant to the paper despite being mentioned (e.g. a Covid-19 paper is cited as evidence that a method works, although it is not used for Covid-19 in the citing paper). |
Figure 1. Results from a content analysis of Covid-19 role for a random sample of 500 journal articles mentioning Covid-19 by 19 March 2021 (Full data: https://doi.org/10.6084/m9.figshare.14599908). |